EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type

Ningning Yao, Qing Hou, Yu Liang, Xin Cao, Bochen Sun, Lijuan Wei, Ruifang Sun, Jianzhong Cao

Cancer Biomarkers · 2024

DOI: 10.3233/cbm-230068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biomarkers, 2024. Verfasst von Ningning Yao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Canc…. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Aspartate Aminotransferases, Biomarkers, Tumor. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Aspartate aminotransferase (AST), an indicator of liver cell damage, was related to the prognosis of certain malignant tumors. OBJECTIVE: This study examined the predictive value of AST in patients with extranodal natural killer/T cell lymphoma (ENKTL). METHODS: We reviewed 183 cases diagnosed with ENKTL and selected 26 U/L as the optimum cut-off value of AST. We used the univariate and multivariate Cox regression to compare the different AST groups’ overall survival (OS) and progression-free survival (PFS). RESULTS: Prior to propensity score matching (PSM), Kaplan-Meier analysis showed that patients in the low AST subgroup had better OS and PFS than the high AST subgroup. Multivariate analysis revealed that AST was an independent indicator for prognosis. After PSM, the low AST subgroup maintained a significantly better OS and PFS than the high AST subgroup. CONCLUSION: AST might represent a significant prognostic marker for ENKTL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Extranodal NK-T-CellAspartate AminotransferasesBiomarkers, TumorHumansFemaleMaleMiddle AgedPrognosisAdultAgedKaplan-Meier EstimateRetrospective StudiesYoung AdultAdolescent

Stichwörter der Autor:innen

Serum aspartate aminotransferaseextranodal natural killer/T cell lymphomanasal typeprognosissurvival

Substanzen

Aspartate AminotransferasesBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Radiotherapy, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi,…
  • Department of Tumor Biobank, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Shanxi,…

Zitieren

APA

Yao, N., Hou, Q., Liang, Y., Cao, X., Sun, B., Wei, L., Sun, R., & Cao, J. (2024). Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type. Cancer Biomarkers. https://doi.org/10.3233/cbm-230068

Vancouver

Yao N, Hou Q, Liang Y, Cao X, Sun B, Wei L, et al. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type. Cancer Biomarkers. 2024. doi:10.3233/cbm-230068

BibTeX
@article{Yao2024,
  author = {Yao, Ningning and Hou, Qing and Liang, Yu and Cao, Xin and Sun, Bochen and Wei, Lijuan and Sun, Ruifang and Cao, Jianzhong},
  title = {Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type},
  journal = {Cancer Biomarkers},
  year = {2024},
  doi = {10.3233/cbm-230068}
}
Kostenlos starten →